Trial Information

Official Title: Randomized Comparison of Monotherapy (Risperidone, Quetiapine, or Olanzapine) Versus Combination Therapy (Risperidone, Quetiapine, or Olanzapine + Divalproex)in the Management of Dementia With Agitation: A Pilot Comparison of Two Standard Therapies

Summary

The purpose of this study is to determine whether an antipsychotic medication alone or an antipsychotic medication in combination with divalproex is the most effective and safest way to treat agitation in elderly patients with dementia.

Phase: Phase 4

Sponsor: Emory University

Overall Contacts:

R. D. Jewart, PhD
404-728-6414
rjewart@emory.edu

J. D. Rosenberg
Phone: 404-728-4784
jdrose4@emory.edu